Cuneyt M. Alper
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Cuneyt M. Alper sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Cuneyt M. Alper: 5 sponsored US clinical trials, none currently recruiting.
Cuneyt M. Alper sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Middle Ear Gas Exchange, with 1 trials.
Upper-quartile sponsor footprint
Cuneyt M. Alper sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Tubomanometry and EarPopper Devices for Eustachian Tube Function Testing
NCT03850197
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3
NCT01925495
Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1
NCT01925482
TransMEM Gas Exchange -- Project 1, Aim 2
NCT01925729
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
NCT00694421
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Therapeutic Areas
How the Cuneyt M. Alper early-phase archive is shaped
5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Middle Ear Gas Exchange (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Cuneyt M. Alper: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Cuneyt M. Alper sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Cuneyt M. Alper page
5 registered trials is a research-attention snapshot, not an endorsement of Cuneyt M. Alper or any single study.
- None of Cuneyt M. Alper's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Middle Ear Gas Exchange is the condition Cuneyt M. Alper studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Middle Ear Gas Exchange trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Cuneyt M. Alper pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.